Fructin is used intravenously as a carbohydrate nutrient. It is converted to liver glycogen and metabolized more rapidly than dextrose without requiring insulin and thus may be used in diabetic patients. Fructin is indicated in patients requiring fluid replacement and caloric feeding. It is better "nitrogen sparer" than glucose.
The volume and rate of infusion of fructose IV solution will depend upon the requirements of the patient and the judgement of attending physician. But the rate of infusion of fructose should not exceed 0.5-1 gm/kg body weight per hour.The usual recommended flow rate for adult is 30-75 drops per minute infused intravenously.
Intravenous administration of Fructin may cause lactic acidosis and hyperuricemia.The rapid infusion of Fructin results in facial flushing, abdominal pain and sweating.
Fructose is contraindicated in certain inborn errors of fructose metabolism, methyl alcohol poisoning, hyperuricemia, liver failure, and lactic acidosis.
Fructin should not be given to patients with hereditary Fructin intolerance. It should be given with caution to patients with impaired kidney function or severe liver damage. Infusion of fluid should be immediately discontinued if rigor arises for any reason during the process. Do not use if the solution is cloudy, contains particles, or after expiry date.
Always consult a registered doctor before taking any medicine. This information is for general knowledge only.